Source: Annual Congress 2009 - Treatment of lung cancer
Disease area: Thoracic oncology

Abstract

Introduction
Lung cancer is the leading cause of cancer-related death in both men and women in Europe. Small cell histotype is considered non operable and is related to poor survival rates. Only chemo- and radiotherapy are proposed to the majority of these patients.
Aim
The comparison of the survival rates between small cell lung cancer (SCLC) patients who received radiotherapy and chemotherapy versus those who received only chemotherapy.
Patients
We performed a retrospective analysis of patients with newly diagnosed SCLC (11 pts with limited and 26 pts with extensive disease), who were admitted to our department between January 2003 and September 2008.
We studied 37 patients: 34 males and 3 females, with mean age (± SD): 65.2 ± 9.4 years.
Results
32 patients were current or ex-smokers, while 5 were non smokers. Mean tobacco consumption was 69.1 ± 40.9 pack/yrs. Seventeen out of 37 patients had received chemoradiotherapy and their mean survival rate (± SD) was 13.3 ± 10.8. Twenty patients had received only chemotherapy and their mean survival rate (± SD) was 13.2 ± 9.5.
Conclusions
No benefit was observed in terms of survival for SCLC patients who received chemoradiotherapy comparing to those who received only chemotherapy.

Rating:

Share or cite this content

Citations should be made in the following way:
G. Hillas, S. Nikolakopoulou, I. Kostara, K. Sagris, H. Dimitropoulos, P. Bakakos, D. Veldekis, F. Vlastos (Athens, Greece). Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients. Eur Respir J 2009; 34: Suppl. 53, 2644

Member's Comments

No comment yet.

Related content which might interest you: Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005 Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004 Rates of treatment response and median survival in advanced non small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004 Influence of dose of radiotherapy on quality of life in patients with non-small cell lung cancer treated by radiotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 Comparison of quality of life in patients with non-small cell lung cancer treated by chemotherapy or radiotherapy Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004 Early concurrent chemoradiotherapy for limited small cell lung cancer (LSCLC). Analysis of toxicity and survival of 30 consecutive patients Source: Eur Respir J 2002; 20: Suppl. 38, 464s Year: 2002 Treatment of limited disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 299–309 Year: 2009 The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment Source: Annual Congress 2007 - Therapy of thoracic malignancies Year: 2007 Correlation between parameters of quality of life in patients with non-small cell lung cancer treated by chemotherapy and radiotherapy Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006 Palliative treatment of locally advanced non small cell lung cancer with weekly fraction radiotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 496s Year: 2005 Tobacco exposure and survival in non small cell lung cancer patients treated with erlotinib Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment Year: 2005 Retrospective assessment of non small cell lung cancer stage IIIA-IIIB, treated with neoadjuvant chemotherapy Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Factors predicting complete surgical resection after induction chemotherapy in patients with initially unresectable non-small cell lung cancer (NSCLC) treated in a randomised trial Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003 Is there any place for perioperative radiation therapy? Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005